Immunocore
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $75,400 | $70,502 | $105,635 | $62,624 |
Gross Profit | 73,693 | 70,256 | 105,882 | 62,357 |
EBITDA | -4,866 | -17,423 | -18,737 | 17,098 |
EBIT | -5,858 | -18,434 | -18,858 | 15,434 |
Net Income | -11,616 | -24,436 | -26,417 | 2,315 |
Net Change In Cash | 75,400 | 70,502 | 105,635 | 62,624 |
Free Cash Flow | 23,141 | -5,017 | -11,439 | 4,137 |
Cash | 504,985 | 832,821 | 442,626 | 442,679 |
Basic Shares | 50,014 | 49,877 | 48,888 | 54,158 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $249,428 | $143,737 | $26,520 | $30,114 |
Gross Profit | 248,391 | 143,283 | -46,706 | -44,695 |
EBITDA | -38,470 | -36,453 | -135,115 | -75,447 |
EBIT | -42,560 | -41,788 | -142,706 | -84,423 |
Net Income | -55,287 | -41,224 | -131,523 | -74,093 |
Net Change In Cash | 249,428 | 143,737 | 26,520 | 30,114 |
Free Cash Flow | -2,485 | -33,466 | -130,757 | -63,648 |
Cash | 442,626 | 332,539 | 237,886 | 129,716 |
Basic Shares | 48,888 | 45,714 | 43,862 | 31,782 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.49 |
2024-06-30 | -$0.23 |
2024-03-31 | -$0.49 |
2023-12-31 | -$32.22 |
